DANIELLE CONSTANDIS: Open Payments
NPI 1609478684 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 41 payments from 15 companies in 2025. Trend: 2023 $2,702 · 2024 $1,640 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $235 |
| Alnylam Pharmaceuticals Inc. | 10 | $141 |
| BridgeBio Pharma, Inc. | 6 | $113 |
| Merck Sharp & Dohme LLC | 4 | $63 |
| Teleflex LLC | 1 | $60 |
| AtriCure, Inc. | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Astellas Pharma US Inc | 2 | $42 |
| BrioHealth Solutions, Inc. | 1 | $35 |
Products named: Attruby, ONPATTRO, VERQUVO, ATRICLIP LAA EXCLUSION SYSTEM, Cresemba, JARDIANCE, BRIOVAD, AMVUTTRA.
Industry payments across NJ — which companies pay providers there.
